These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1312922)

  • 1. Two macrolide antimicrobials approved for marketing.
    Clin Pharm; 1992 Feb; 11(2):98. PubMed ID: 1312922
    [No Abstract]   [Full Text] [Related]  

  • 2. New macrolide antibiotics: clarithromycin and azithromycin.
    Stott GA
    Am Fam Physician; 1992 Sep; 46(3):863-9. PubMed ID: 1325106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-acting erythromycins: assessing their role in treating outpatient odontogenic infections.
    Alexander RE; Grogan DM
    Tex Dent J; 2009 Apr; 126(4):326-33. PubMed ID: 19472551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarithromycin and azithromycin.
    Med Lett Drugs Ther; 1992 May; 34(870):45-7. PubMed ID: 1315414
    [No Abstract]   [Full Text] [Related]  

  • 5. Two new macrolide antibiotics: clarithromycin and azithromycin.
    Holdcroft C
    Nurse Pract; 1993 Jan; 18(1):50, 53. PubMed ID: 8380492
    [No Abstract]   [Full Text] [Related]  

  • 6. New macrolide antibiotics: azithromycin and clarithromycin.
    Neu HC
    Ann Intern Med; 1992 Mar; 116(6):517-9. PubMed ID: 1310839
    [No Abstract]   [Full Text] [Related]  

  • 7. Divergent proarrhythmic potential of macrolide antibiotics despite similar QT prolongation: fast phase 3 repolarization prevents early afterdepolarizations and torsade de pointes.
    Milberg P; Eckardt L; Bruns HJ; Biertz J; Ramtin S; Reinsch N; Fleischer D; Kirchhof P; Fabritz L; Breithardt G; Haverkamp W
    J Pharmacol Exp Ther; 2002 Oct; 303(1):218-25. PubMed ID: 12235254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of macrolide antibiotics on nitric oxide synthase and xanthine oxidase activities, and malondialdehyde level in erythrocyte of the guinea pigs with experimental otitis media with effusion.
    Aktan B; Taysi S; Gümüştekin K; Uçüncü H; Memişoğullari R; Save K; Bakan N
    Pol J Pharmacol; 2003; 55(6):1105-10. PubMed ID: 14730107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin and clarithromycin.
    Hammerschlag MR
    Pediatr Ann; 1993 Mar; 22(3):160, 162-4, 166. PubMed ID: 8385308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Macrolide antibiotic resistance rates and phenotypes of group A beta hemolytic streptococci isolated between the years 1999-2000 and 2001-2002].
    Senses Z; Baysallar M; Gür D; Doğanci L
    Mikrobiyol Bul; 2003 Oct; 37(4):225-34. PubMed ID: 14748258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new macrolactones: clarithromycin (Biaxin) and azithromycin (Zithromax).
    Peltier K
    Conn Med; 1992 Jul; 56(7):371-4. PubMed ID: 1330429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrolide antibiotics.
    Pallasch TJ
    Dent Today; 1997 Nov; 16(11):72, 74-5, 78-9. PubMed ID: 9560736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic interaction study between midazolam and the macrolide antibiotics, erythromycin, clarithromycin, and the azalide azithromycin.
    Yeates RA; Laufen H; Zimmermann T; Schumacher T
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):577-9. PubMed ID: 9455717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefpodoxime marketing approved by FDA.
    Clin Pharm; 1992 Dec; 11(12):999-1000. PubMed ID: 1286555
    [No Abstract]   [Full Text] [Related]  

  • 16. Pulmonary disposition of erythromycin, azithromycin, and clarithromycin in foals.
    Suarez-Mier G; Giguère S; Lee EA
    J Vet Pharmacol Ther; 2007 Apr; 30(2):109-15. PubMed ID: 17348895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical results using two new antibiotics--clarithromycin and temafloxacin.
    Oncology (Williston Park); 1991 Oct; 5(10):142, 145-6. PubMed ID: 1664229
    [No Abstract]   [Full Text] [Related]  

  • 20. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.
    Mason EO; Wald ER; Bradley JS; Barson WJ; Kaplan SL;
    Pediatr Infect Dis J; 2003 Jul; 22(7):623-7. PubMed ID: 12867838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.